Mecobalamin

甲钴胺

Report date: 2025/03/06 14:53:08
NME

Base Information

Drug NameMecobalamin
Drug Alias NameMecobalaminumMethyl cobalamineIntranasal MethylCobalaminMecobalamin nasal sprayMethyl vitamin B12 +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 stimulants
TargetsDNA (cytosine-5)-methyltransferase 1
Therapy Area/IndicationsAutistic DisorderVitamin B 12 DeficiencyNeuritis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenNew Zealand +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLinnaeus UniversityEisai Co Ltd
Inactive CompaniesUniversity Of California San FranciscoThe University Of California DavisYonsei University
Active IndicationsNeuritisNeuralgiaPeripheral Nervous System Diseases +[4] 
Inactive IndicationsAutistic DisorderVitamin B 12 DeficiencyAmyotrophic Lateral Sclerosis

Other Information

ATC CodeB03BA05
Related LinksWikipediaDrugBankKEGG